Socioeconomic Status Drives Racial Disparities in HPV-negative Head and Neck Cancer Outcomes

被引:23
|
作者
Lenze, Nicholas R. [1 ]
Farquhar, Douglas [1 ]
Sheth, Siddharth [2 ]
Zevallos, Jose P. [3 ]
Blumberg, Jeffrey [1 ]
Lumley, Catherine [1 ]
Patel, Samip [1 ]
Hackman, Trevor [1 ]
Weissler, Mark C. [1 ]
Yarbrough, Wendell G. [1 ,5 ]
Zanation, Adam M. [1 ]
Olshan, Andrew F. [4 ]
机构
[1] Univ N Carolina, Sch Med, Dept Otolaryngol Head & Neck Surg, 170 Manning Dr,Campus Box 7070, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Med, Div Hematol & Oncol, Chapel Hill, NC 27515 USA
[3] Washington Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, St Louis, MO 63110 USA
[4] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA
[5] Univ N Carolina, Dept Pathol, Chapel Hill, NC 27515 USA
来源
LARYNGOSCOPE | 2021年 / 131卷 / 06期
关键词
Head and neck neoplasms; race; disparities; access to care; socioeconomic status; survival; SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; OROPHARYNGEAL CANCER; AFRICAN-AMERICAN; HEALTH LITERACY; UNITED-STATES; ORAL-HEALTH; SURVIVAL; IMPACT; RACE;
D O I
10.1002/lary.29252
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives/Hypothesis To determine drivers of the racial disparity in stage at diagnosis and overall survival (OS) between black and white patients with HPV-negative head and neck squamous cell carcinoma (HNSCC). Study Design Retrospective cohort study. Methods Data were examined from of a population-based HNSCC study in North Carolina. Multivariable logistic regression and Cox proportional hazards models were used to assess racial disparities in stage at diagnosis and OS with sequential adjustment sets. Results A total of 340 black patients and 864 white patients diagnosed with HPV-negative HNSCC were included. In the unadjusted model, black patients had increased odds of advanced T stage at diagnosis (OR 2.0; 95% CI [1.5-2.5]) and worse OS (HR 1.3, 95% CI 1.1-1.6) compared to white patients. After adjusting for age, sex, tumor site, tobacco use, and alcohol use, the racial disparity persisted for advanced T-stage at diagnosis (OR 1.7; 95% CI [1.3-2.3]) and showed a non-significant trend for worse OS (HR 1.1, 95% CI 0.9-1.3). After adding SES to the adjustment set, the association between race and stage at diagnosis was lost (OR: 1.0; 95% CI [0.8-1.5]). Further, black patients had slightly favorable OS compared to white patients (HR 0.8, 95% CI [0.6-1.0]; P = .024). Conclusions SES has an important contribution to the racial disparity in stage at diagnosis and OS for HPV-negative HNSCC. Low SES can serve as a target for interventions aimed at mitigating the racial disparities in head and neck cancer. Level of Evidence 4 Laryngoscope, 2020
引用
收藏
页码:1301 / 1309
页数:9
相关论文
共 50 条
  • [41] Development and Validation of a Clinical and Genomic Generalized Competing Event Model in HPV-Negative Head and Neck Cancer
    Carmona, R.
    Venigalla, S.
    Reddy, V. K.
    Williams, G. R.
    Lukens, J. N.
    Swisher-McClure, S. D.
    Ghiam, A. Fotouhi
    Lin, A.
    Mell, L. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E670 - E670
  • [42] Candidate Biomarkers for HPV-Negative Head and Neck Cancer Identified via Gene Expression Barcode Analysis
    Yang, Shiayin F.
    Bier-Laning, Carol M.
    Adams, William
    Zilliox, Michael J.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2016, 155 (03) : 416 - 422
  • [43] Neoadjuvant Capecitabine in Operable HPV-Negative Head and Neck Cancer: Fortuitous Findings in a Resource Constrained Setting
    Mascarella, Marco A.
    Richardson, Keith
    Mlynarek, Alex
    Hier, Michael P.
    Caglar, Derin
    Florianova, Livia
    Pusztaszeri, Marc Philippe
    Sultanem, Khalil
    Sadeghi, Nader
    Bouganim, Nathaniel
    Esfahani, Khashayar
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2024, 171 (06) : 1773 - 1779
  • [44] Differential expression of cancer stem cell markers in HPV-positive and HPV-negative squamous cell carcinoma of the head and neck
    Volavsek, M.
    Zidar, N.
    VIRCHOWS ARCHIV, 2014, 465 : S34 - S35
  • [45] Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer
    Stoegbauer, Fabian
    Beck, Susanne
    Ourailidis, Iordanis
    Hess, Jochen
    Poremba, Christopher
    Lauterbach, Maren
    Wollenberg, Barbara
    Buchberger, Anna Maria Stefanie
    Jesinghaus, Moritz
    Schirmacher, Peter
    Stenzinger, Albrecht
    Weichert, Wilko
    Boxberg, Melanie
    Budczies, Jan
    BRITISH JOURNAL OF CANCER, 2023, 128 (12) : 2295 - 2306
  • [46] Salivary DNA methylation panel to diagnose HPV-positive and HPV-negative head and neck cancers
    Yenkai Lim
    Yunxia Wan
    Dimitrios Vagenas
    Dmitry A. Ovchinnikov
    Chris F. L. Perry
    Melissa J. Davis
    Chamindie Punyadeera
    BMC Cancer, 16
  • [47] Salivary DNA methylation panel to diagnose HPV-positive and HPV-negative head and neck cancers
    Lim, Yenkai
    Wan, Yunxia
    Vagenas, Dimitrios
    Ovchinnikov, Dmitry A.
    Perry, Chris F. L.
    Davis, Melissa J.
    Punyadeera, Chamindie
    BMC CANCER, 2016, 16
  • [48] Effect of ATR Inhibition in RT Response of HPV-Negative and HPV-Positive Head and Neck Cancers
    Dok, Ruveyda
    Glorieux, Mary
    Bamps, Marieke
    Nuyts, Sandra
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (04) : 1 - 12
  • [49] Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer
    Fabian Stögbauer
    Susanne Beck
    Iordanis Ourailidis
    Jochen Hess
    Christopher Poremba
    Maren Lauterbach
    Barbara Wollenberg
    Anna Maria Stefanie Buchberger
    Moritz Jesinghaus
    Peter Schirmacher
    Albrecht Stenzinger
    Wilko Weichert
    Melanie Boxberg
    Jan Budczies
    British Journal of Cancer, 2023, 128 : 2295 - 2306
  • [50] Development and Characterization of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Tumorgrafts
    Kimple, Randall J.
    Harari, Paul M.
    Torres, Alexandra D.
    Yang, Robert Z.
    Soriano, Benjamin J.
    Yu, Menggang
    Armstrong, Eric A.
    Blitzer, Grace C.
    Smith, Molly A.
    Lorenz, Laurel D.
    Lee, Denis
    Yang, David T.
    McCulloch, Timothy M.
    Hartig, Gregory K.
    Lambert, Paul F.
    CLINICAL CANCER RESEARCH, 2013, 19 (04) : 855 - 864